Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asklepios BioPharmaceutical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011821
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskBio009, BNP-CHF, BNP-TLE, BNP-FVIII, BNP-RP and BNP-OA. AskBio also offers products for the treatment of muscular dystrophy, hemophilia B, congestive heart failure, epilepsy, hemophilia A, retinitis pigmentos a and osteoarthritis. The company collaborates with corporate, foundation, and academic organizations. It caters to pharmaceutical and biotechnology companies throughout the country. AskBio is headquartered in Chapel Hill, North Carolina, the US.

Asklepios BioPharmaceutical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Licensing Agreements 12
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Acquisition 18
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc – Key Competitors 19
Asklepios BioPharmaceutical Inc – Key Employees 20
Asklepios BioPharmaceutical Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc, Key Competitors 19
Asklepios BioPharmaceutical Inc, Key Employees 20

★海外企業調査レポート[Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IRF European Finance Investments, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' IRF European Finance Investment …
  • Hedcor, Inc.:企業のM&A・提携動向(発電分野)
    Summary Hedcor, Inc. (Hedcor), a subsidiary of Aboitiz Power Corporation, formerly Benguet Hydro power Corp renewable energy company that develops, installs and maintains mini hydro power plants. The company generates renewable energy from run-of-river hydropower systems. Hedcor develops a Manolo Fo …
  • Winteam Pharmaceutical Group Limited (570):企業概要、財務及び戦略的SWOT分析
    Summary Winteam Pharmaceutical Group Limited (Winteam) is a pharmaceutical company. The company carries out research, manufacturing and sale of Chinese traditional patent medicines, chemical medicines and biological medicines. It provides granules, tablets, capsules, medical wine, antibiotics, and o …
  • AviChina Industry and Technology Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AviChina Industry and Technolog …
  • Barwa Real Estate Company Q.S.C.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Barwa Real Estate Company Q.S.C …
  • Acetylon Pharmaceuticals, Inc.:製品開発パイプライン動向2015
    Acetylon Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Acetylon Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Acetylon Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides compreh …
  • Bionomics Ltd (BNO):企業財務及び戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that offers therapies. The company discovers and develops drugs for treatment of cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. Its products include BNC 105, BNC210, K v 1.3 blockers, …
  • Southern California Edison Company(エネルギー分野):企業M&A動向
    Summary Southern California Edison Company (SCE) is an electricity utility company supplying power to central, coastal and southern California. It generates power from coal, nuclear, hydro power and renewable sources such as wind, solar, biomass and geothermal. The company's retail operations are re …
  • Diageo plc:企業概要・SWOT・財務分析
    Summary Canadean's "Diageo plc : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, …
  • Hargreaves Services plc:企業の戦略・SWOT・財務分析
    SummaryHargreaves Services plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Alpha Packaging LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alpha Packaging LLC Mergers and …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務分析
    SummaryArgonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Key Petroleum Limited (KEY):企業概要、財務及び戦略的SWOT分析
    Summary Key Petroleum Limited (Key Petroleum) is an oil and gas service provider. The company develops and explores conventional and unconventional projects in Western Australia. Its projects include Canning Basin and Perth Basin. The company holds interests in six exploration permits such as EP 438 …
  • Nantex Industry Co Ltd (2108):企業概要、財務及び戦略的SWOT分析
    Summary Nantex Industry Co Ltd (Nantex) is a chemical company. The company manufactures and distributes synthetic rubber products. It manufactures various grades of MBR, NBR and SBR latexes. Nantex's products include inner shoe soles, synthetic rubber latex, carbon masterbatch compounds, acrylonitri …
  • Tyman PLC (Formerly Lupus Capital plc):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tyman PLC (Formerly Lupus Capit …
  • Whiting Petroleum Corporation:企業の戦略・SWOT・財務分析
    SummaryWhiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Lightbridge Corporation (LTBR):企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Famy Care, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Famy Care, Ltd. Mergers and Acq …
  • SpePharm Holding B.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SpePharm Holding B.V. Mergers a …
  • Thai Poly Acrylic Public Company Limited (TPA):企業財務及び戦略的SWOT分析
    Summary Thai Poly Acrylic Public Company Limited (TPA), a subsidiary of Lucite International, Inc. is a chemical company that manufactures and distributes acrylic sheets. The company’s products include cast acrylic sheet, acrylic sheet, special grade, impact modified, sanitary ware, perspex LMS and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆